REG3A and central nervous system cancer: Since 1998, REG3A has been discovered to be expressed in various tumor cells and tissues, including in gastric cancer, breast cancer, glioma, pancreatic ductal adenocarcinoma, hepatocellular carcinoma, colorectal carcinoma, and pancreatic cancer (Table 1).